Featured Research

from universities, journals, and other organizations

Tiny Molecular Change Inactivates Tumor Suppressor Gene In Neurofibromatosis

Date:
January 10, 2002
Source:
Washington University School Of Medicine
Summary:
A tiny change in the cells of patients with neurofibromatosis (NF) seems to contribute to formation of aggressive tumors and could help explain why the disease — which predisposes patients to develop tumors — affects people in different ways.

St. Louis, Jan. 8, 2002 – A tiny change in the cells of patients with neurofibromatosis (NF) seems to contribute to formation of aggressive tumors and could help explain why the disease — which predisposes patients to develop tumors — affects people in different ways.

Reporting in the January 2002 issue of the American Journal of Human Genetics, investigators at Washington University School of Medicine in St. Louis describe a small, molecular variation in some tumor samples taken from neurofibromatosis patients.

“Neurofibromatosis is a common, inherited genetic disease that affects about one in 3,500 people,” says principal investigator Nicholas O. Davidson, M.D., professor of medicine and of molecular biology and pharmacology and director of the Division of Gastroenterology at Washington University School of Medicine. “The gene responsible spans a large region of chromosome 17, but we have found that a very small change in the NF gene’s messenger RNA can inactivate the final product of this gene, a protein called neurofibromin.”

Neurofibromin suppresses tumor development. When it is inactivated, its tumor-suppressing ability is lost, and patients with NF develop a wide variety of tumors. Approximately 25 percent of tumors studied had evidence of a single nucleotide RNA change — called RNA editing — that occurs when messenger RNA is edited before leaving the nucleus of the cell. Cells that did have the change, however, seemed to be more aggressive tumors, and a substantial percentage was malignant.

Since patients inherit two copies of the NF gene, most researchers believe in a “two hit” mechanism that launches neurofibromatosis. The first hit comes when a person is born with one copy of the gene already mutated to cause the disease, but that person would actually develop clinical manifestations of NF only after the second copy of the gene was “hit.” The faulty RNA editing seen by Davidson could provide that second hit.

“When a cell makes a protein,” explains Davidson, “the first steps occur as the DNA encoding the gene is copied into a strand of messenger RNA (mRNA). The mRNA specifies the eventual sequence of the final protein. If a reading error or nucleotide sequence change occurs as the DNA is copied into mRNA, it can change both the amino acid sequence and the properties of the final protein. These same effects can be introduced through RNA editing.”

The type of error that Davidson found in some NF tumor samples is known as C ->U RNA editing. In human cells, DNA and RNA molecules consist of strands of building blocks known as nucleotides that are described as a sequence of four letters. For RNA, the letters are ACGU. Davidson and colleagues found that when the NF gene is copied into mRNA, a C at a specific spot is replaced by a U. That changes the protein made by the gene by introducing a signal to stop translation of the mRNA. This process in effect turns off the neurofibromin tumor suppressor, making patients vulnerable to tumor formation.

Davidson and colleagues first observed such C ->U editing in an abundant gene expressed in the human gastrointestinal tract.

“A gene normally made in the small intestine, called apolipoprotein B, is absolutely required for lipid transport,” Davidson says. “Human small intestinal apolipoprotein B undergoes C ->U editing as a normal part of its regulation to produce a shorter version of a protein that orchestrates fat absorption. Our study shows, however, that the same RNA editing machinery essential to normal function in the intestine can inactivate the neurofibromin tumor suppressor in some patients with neurofibromatosis.”

The evidence that RNA editing occurs the same way in both the gut and in tumor tissue comes from the presence of an enzyme called apobec-1 (apoB RNA editing catalytic component #1). Usually apobec-1 is found only in the gut. But Davidson and his colleagues discovered apobec-1 in nerve sheath tumor samples taken from patients with neurofibromatosis. The finding could mean that C ->U editing also might occur in tumors elsewhere in the body as an agent that disables tumor suppressor genes. Davidson and colleagues plan to test other tumor samples for the presence of apobec-1.

“We found apobec-1 in eight of 34 neurofibromatosis tumors we tested, and many of those tumors were more aggressive than the ones that didn’t show RNA editing. Now we need to look at more tumors and see whether this pathway may be involved in the formation of tumors generally, or whether those tumors that involve RNA editing really are more aggressive than other types of tumors in neurofibromatosis,” he says.

Davidson also hopes to look at tumors from other diseases to see whether RNA editing might be involved in creating various types of cancer.

###

Reference: Debnath Mukhopadhyay, et. al., “C ->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the Type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme,” American Journal of Human Genetics, vol. 70(1), 38-50, Jan. 2002.

This research was supported by grants from the National Institutes of Health.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Tiny Molecular Change Inactivates Tumor Suppressor Gene In Neurofibromatosis." ScienceDaily. ScienceDaily, 10 January 2002. <www.sciencedaily.com/releases/2002/01/020109072958.htm>.
Washington University School Of Medicine. (2002, January 10). Tiny Molecular Change Inactivates Tumor Suppressor Gene In Neurofibromatosis. ScienceDaily. Retrieved September 24, 2014 from www.sciencedaily.com/releases/2002/01/020109072958.htm
Washington University School Of Medicine. "Tiny Molecular Change Inactivates Tumor Suppressor Gene In Neurofibromatosis." ScienceDaily. www.sciencedaily.com/releases/2002/01/020109072958.htm (accessed September 24, 2014).

Share This



More Health & Medicine News

Wednesday, September 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Costs Keep Mounting

Ebola Costs Keep Mounting

Reuters - Business Video Online (Sep. 23, 2014) The WHO has warned up to 20,000 people could be infected with Ebola over the next few weeks. As Sonia Legg reports, the implications for the West African countries suffering from the disease are huge. Video provided by Reuters
Powered by NewsLook.com
Ebola Cases Could Reach 1.4 Million Within 4 Months

Ebola Cases Could Reach 1.4 Million Within 4 Months

Newsy (Sep. 23, 2014) Health officials warn that without further intervention, the number of Ebola cases in Liberia and Sierra Leone could reach 1.4 million by January. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Cases to Triple in Weeks Without Drastic Action

WHO: Ebola Cases to Triple in Weeks Without Drastic Action

AFP (Sep. 23, 2014) The number of Ebola infections will triple to 20,000 by November, soaring by thousands every week if efforts to stop the outbreak are not stepped up radically, the WHO warned in a study on Tuesday. Duration: 01:01 Video provided by AFP
Powered by NewsLook.com
5 Ways Men Can Prevent Most Heart Attacks

5 Ways Men Can Prevent Most Heart Attacks

Newsy (Sep. 23, 2014) No surprise here: A recent study says men can reduce their risk of heart attack by maintaining a healthy lifestyle, which includes daily exercise. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins